Boesen Am

Statistics

Publications

Citations

119

H-Index

Active since

1991

Affiliations

Rigshospitalet(Current)

Boesen Am is an author at Rigshospitalet specializing in hematologic oncology, chemotherapy in hematologic malignancies, and myeloablative chemotherapy.

Publications per year

1991–1997

Publications

Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.

Hansen Op, J Pedersen-Bjergaard, J Ellegaard et al. · PubMed · 1991 · 71 citations

Medicine, Hematology, Oncology +15

Antibody-induced modulation and intracellular transport of CD10 and CD19 antigens in human B-cell lines: an immunofluorescence and immunoelectron microscopy study

Stanislaw Pulczynski, Boesen Am, OM Jensen · Blood · 1993 · 35 citations · Full text

Life Sciences, Cell Biology, Immunology +12

Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial

Peter de Nully Brown, T Hoffmann, Hansen Op et al. · Leukemia · 1997 · 13 citations

Medicine, Oncology, Pharmacology +17

1–3 of 3